nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC22A8—Furosemide—dilated cardiomyopathy	0.509	1	CbGbCtD
Famotidine—Knee pain—Lisinopril—dilated cardiomyopathy	0.04	0.0942	CcSEcCtD
Famotidine—Benign prostatic hyperplasia—Furosemide—dilated cardiomyopathy	0.029	0.0683	CcSEcCtD
Famotidine—SLC22A2—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.00899	0.135	CbGpPWpGaD
Famotidine—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00876	0.132	CbGpPWpGaD
Famotidine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00826	0.0195	CcSEcCtD
Famotidine—Appetite absent—Lisinopril—dilated cardiomyopathy	0.00758	0.0179	CcSEcCtD
Famotidine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.0061	0.0918	CbGpPWpGaD
Famotidine—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00604	0.0142	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00604	0.0142	CcSEcCtD
Famotidine—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00572	0.0135	CcSEcCtD
Famotidine—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00559	0.0132	CcSEcCtD
Famotidine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00534	0.0126	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00512	0.0121	CcSEcCtD
Famotidine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00482	0.0114	CcSEcCtD
Famotidine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00439	0.0103	CcSEcCtD
Famotidine—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00429	0.0101	CcSEcCtD
Famotidine—Viral infection—Lisinopril—dilated cardiomyopathy	0.00417	0.00984	CcSEcCtD
Famotidine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00417	0.00984	CcSEcCtD
Famotidine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00415	0.00979	CcSEcCtD
Famotidine—Swelling—Furosemide—dilated cardiomyopathy	0.00414	0.00974	CcSEcCtD
Famotidine—Alopecia—Spironolactone—dilated cardiomyopathy	0.0041	0.00966	CcSEcCtD
Famotidine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00388	0.00915	CcSEcCtD
Famotidine—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00382	0.00899	CcSEcCtD
Famotidine—Neck pain—Lisinopril—dilated cardiomyopathy	0.00382	0.00899	CcSEcCtD
Famotidine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00372	0.0561	CbGpPWpGaD
Famotidine—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00366	0.00863	CcSEcCtD
Famotidine—Wheezing—Lisinopril—dilated cardiomyopathy	0.00366	0.00863	CcSEcCtD
Famotidine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00361	0.00852	CcSEcCtD
Famotidine—Irritability—Furosemide—dilated cardiomyopathy	0.00348	0.0082	CcSEcCtD
Famotidine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00332	0.00783	CcSEcCtD
Famotidine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0033	0.00776	CcSEcCtD
Famotidine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00328	0.00774	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00328	0.00774	CcSEcCtD
Famotidine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00323	0.0076	CcSEcCtD
Famotidine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00312	0.00734	CcSEcCtD
Famotidine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.003	0.00708	CcSEcCtD
Famotidine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00295	0.00695	CcSEcCtD
Famotidine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00293	0.0069	CcSEcCtD
Famotidine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00291	0.00686	CcSEcCtD
Famotidine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00288	0.00678	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00279	0.00657	CcSEcCtD
Famotidine—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00274	0.00645	CcSEcCtD
Famotidine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00272	0.0064	CcSEcCtD
Famotidine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00272	0.0064	CcSEcCtD
Famotidine—Face oedema—Lisinopril—dilated cardiomyopathy	0.00264	0.00623	CcSEcCtD
Famotidine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00262	0.00618	CcSEcCtD
Famotidine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00262	0.00617	CcSEcCtD
Famotidine—Irritability—Lisinopril—dilated cardiomyopathy	0.00261	0.00615	CcSEcCtD
Famotidine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00261	0.00614	CcSEcCtD
Famotidine—HRH2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00249	0.0375	CbGpPWpGaD
Famotidine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00246	0.00581	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00246	0.00581	CcSEcCtD
Famotidine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00243	0.00572	CcSEcCtD
Famotidine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00239	0.00562	CcSEcCtD
Famotidine—Influenza—Lisinopril—dilated cardiomyopathy	0.00237	0.00557	CcSEcCtD
Famotidine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00235	0.00554	CcSEcCtD
Famotidine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00233	0.00549	CcSEcCtD
Famotidine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00233	0.00548	CcSEcCtD
Famotidine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00228	0.00536	CcSEcCtD
Famotidine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00225	0.00531	CcSEcCtD
Famotidine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00225	0.00531	CcSEcCtD
Famotidine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00225	0.00529	CcSEcCtD
Famotidine—Dysuria—Lisinopril—dilated cardiomyopathy	0.00221	0.00521	CcSEcCtD
Famotidine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00221	0.00521	CcSEcCtD
Famotidine—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.0022	0.00518	CcSEcCtD
Famotidine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00218	0.00513	CcSEcCtD
Famotidine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00218	0.00513	CcSEcCtD
Famotidine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00216	0.00509	CcSEcCtD
Famotidine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00215	0.00507	CcSEcCtD
Famotidine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00211	0.00498	CcSEcCtD
Famotidine—Depression—Lisinopril—dilated cardiomyopathy	0.0021	0.00496	CcSEcCtD
Famotidine—Vomiting—Spironolactone—dilated cardiomyopathy	0.0021	0.00494	CcSEcCtD
Famotidine—HRH2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00209	0.0315	CbGpPWpGaD
Famotidine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00209	0.00493	CcSEcCtD
Famotidine—Rash—Spironolactone—dilated cardiomyopathy	0.00208	0.0049	CcSEcCtD
Famotidine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00208	0.00489	CcSEcCtD
Famotidine—Headache—Spironolactone—dilated cardiomyopathy	0.00206	0.00486	CcSEcCtD
Famotidine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00206	0.00484	CcSEcCtD
Famotidine—Anaemia—Furosemide—dilated cardiomyopathy	0.00203	0.00478	CcSEcCtD
Famotidine—Agitation—Furosemide—dilated cardiomyopathy	0.00202	0.00476	CcSEcCtD
Famotidine—HRH2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00202	0.0304	CbGpPWpGaD
Famotidine—Haematuria—Lisinopril—dilated cardiomyopathy	0.00201	0.00474	CcSEcCtD
Famotidine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00198	0.00466	CcSEcCtD
Famotidine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00197	0.00464	CcSEcCtD
Famotidine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00197	0.00463	CcSEcCtD
Famotidine—Nausea—Spironolactone—dilated cardiomyopathy	0.00196	0.00461	CcSEcCtD
Famotidine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00193	0.00454	CcSEcCtD
Famotidine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00189	0.00446	CcSEcCtD
Famotidine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00188	0.00444	CcSEcCtD
Famotidine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00188	0.00443	CcSEcCtD
Famotidine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00183	0.00431	CcSEcCtD
Famotidine—Confusional state—Furosemide—dilated cardiomyopathy	0.00181	0.00426	CcSEcCtD
Famotidine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00179	0.00422	CcSEcCtD
Famotidine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00179	0.00422	CcSEcCtD
Famotidine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00177	0.00416	CcSEcCtD
Famotidine—Shock—Furosemide—dilated cardiomyopathy	0.00176	0.00416	CcSEcCtD
Famotidine—Flushing—Lisinopril—dilated cardiomyopathy	0.00176	0.00414	CcSEcCtD
Famotidine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00176	0.00414	CcSEcCtD
Famotidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00175	0.0264	CbGpPWpGaD
Famotidine—Anorexia—Furosemide—dilated cardiomyopathy	0.00171	0.00403	CcSEcCtD
Famotidine—HRH2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0017	0.0256	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00169	0.0255	CbGpPWpGaD
Famotidine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00169	0.00399	CcSEcCtD
Famotidine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00167	0.00394	CcSEcCtD
Famotidine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00166	0.00391	CcSEcCtD
Famotidine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00161	0.0038	CcSEcCtD
Famotidine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00161	0.00379	CcSEcCtD
Famotidine—Back pain—Lisinopril—dilated cardiomyopathy	0.00159	0.00376	CcSEcCtD
Famotidine—Somnolence—Furosemide—dilated cardiomyopathy	0.00159	0.00376	CcSEcCtD
Famotidine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00158	0.00373	CcSEcCtD
Famotidine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00156	0.00367	CcSEcCtD
Famotidine—Fatigue—Furosemide—dilated cardiomyopathy	0.00155	0.00364	CcSEcCtD
Famotidine—Pain—Furosemide—dilated cardiomyopathy	0.00153	0.00361	CcSEcCtD
Famotidine—Constipation—Furosemide—dilated cardiomyopathy	0.00153	0.00361	CcSEcCtD
Famotidine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00152	0.00359	CcSEcCtD
Famotidine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00151	0.00355	CcSEcCtD
Famotidine—Syncope—Lisinopril—dilated cardiomyopathy	0.00148	0.00348	CcSEcCtD
Famotidine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00148	0.00348	CcSEcCtD
Famotidine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00148	0.00348	CcSEcCtD
Famotidine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00147	0.00345	CcSEcCtD
Famotidine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00146	0.00343	CcSEcCtD
Famotidine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00145	0.00341	CcSEcCtD
Famotidine—Cough—Lisinopril—dilated cardiomyopathy	0.00144	0.00339	CcSEcCtD
Famotidine—Urticaria—Furosemide—dilated cardiomyopathy	0.00142	0.00336	CcSEcCtD
Famotidine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00142	0.00334	CcSEcCtD
Famotidine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00142	0.00334	CcSEcCtD
Famotidine—Chest pain—Lisinopril—dilated cardiomyopathy	0.0014	0.00331	CcSEcCtD
Famotidine—Myalgia—Lisinopril—dilated cardiomyopathy	0.0014	0.00331	CcSEcCtD
Famotidine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.0014	0.00331	CcSEcCtD
Famotidine—Anxiety—Lisinopril—dilated cardiomyopathy	0.0014	0.00329	CcSEcCtD
Famotidine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00137	0.00323	CcSEcCtD
Famotidine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00136	0.0032	CcSEcCtD
Famotidine—Oedema—Lisinopril—dilated cardiomyopathy	0.00135	0.00317	CcSEcCtD
Famotidine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00135	0.00317	CcSEcCtD
Famotidine—Infection—Lisinopril—dilated cardiomyopathy	0.00134	0.00315	CcSEcCtD
Famotidine—Shock—Lisinopril—dilated cardiomyopathy	0.00132	0.00312	CcSEcCtD
Famotidine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00132	0.00311	CcSEcCtD
Famotidine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00132	0.0031	CcSEcCtD
Famotidine—Asthenia—Furosemide—dilated cardiomyopathy	0.00129	0.00303	CcSEcCtD
Famotidine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00128	0.00302	CcSEcCtD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00127	0.0191	CbGpPWpGaD
Famotidine—Pruritus—Furosemide—dilated cardiomyopathy	0.00127	0.00299	CcSEcCtD
Famotidine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00123	0.00289	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00123	0.00289	CcSEcCtD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00122	0.0184	CbGpPWpGaD
Famotidine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00122	0.00287	CcSEcCtD
Famotidine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00121	0.00285	CcSEcCtD
Famotidine—Somnolence—Lisinopril—dilated cardiomyopathy	0.0012	0.00282	CcSEcCtD
Famotidine—Dizziness—Furosemide—dilated cardiomyopathy	0.00119	0.00279	CcSEcCtD
Famotidine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00118	0.00279	CcSEcCtD
Famotidine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00117	0.00276	CcSEcCtD
Famotidine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00116	0.00273	CcSEcCtD
Famotidine—Pain—Lisinopril—dilated cardiomyopathy	0.00115	0.00271	CcSEcCtD
Famotidine—Constipation—Lisinopril—dilated cardiomyopathy	0.00115	0.00271	CcSEcCtD
Famotidine—Vomiting—Furosemide—dilated cardiomyopathy	0.00114	0.00269	CcSEcCtD
Famotidine—Rash—Furosemide—dilated cardiomyopathy	0.00113	0.00266	CcSEcCtD
Famotidine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00113	0.00266	CcSEcCtD
Famotidine—Headache—Furosemide—dilated cardiomyopathy	0.00112	0.00265	CcSEcCtD
Famotidine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00111	0.00261	CcSEcCtD
Famotidine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.0011	0.00259	CcSEcCtD
Famotidine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00107	0.00252	CcSEcCtD
Famotidine—Nausea—Furosemide—dilated cardiomyopathy	0.00106	0.00251	CcSEcCtD
Famotidine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00106	0.00251	CcSEcCtD
Famotidine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00106	0.00251	CcSEcCtD
Famotidine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000991	0.00234	CcSEcCtD
Famotidine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000965	0.00227	CcSEcCtD
Famotidine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000952	0.00224	CcSEcCtD
Famotidine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00092	0.00217	CcSEcCtD
Famotidine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00089	0.0021	CcSEcCtD
Famotidine—SLC47A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000884	0.0133	CbGpPWpGaD
Famotidine—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000873	0.0132	CbGpPWpGaD
Famotidine—HRH2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000864	0.013	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00086	0.013	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00086	0.013	CbGpPWpGaD
Famotidine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000855	0.00202	CcSEcCtD
Famotidine—Rash—Lisinopril—dilated cardiomyopathy	0.000848	0.002	CcSEcCtD
Famotidine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000847	0.002	CcSEcCtD
Famotidine—Headache—Lisinopril—dilated cardiomyopathy	0.000843	0.00199	CcSEcCtD
Famotidine—SLC47A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.0008	0.012	CbGpPWpGaD
Famotidine—Nausea—Lisinopril—dilated cardiomyopathy	0.000799	0.00188	CcSEcCtD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000797	0.012	CbGpPWpGaD
Famotidine—HRH2—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.0007	0.0105	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00061	0.00919	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000555	0.00836	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000534	0.00804	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000496	0.00748	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000488	0.00734	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000481	0.00724	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000467	0.00704	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000457	0.00689	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000457	0.00689	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000425	0.0064	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000417	0.00628	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000412	0.0062	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00041	0.00618	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000405	0.0061	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000405	0.0061	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000389	0.00587	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000387	0.00583	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000377	0.00568	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000352	0.0053	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000348	0.00525	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000348	0.00525	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000334	0.00503	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000324	0.00488	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000314	0.00472	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00029	0.00437	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000282	0.00425	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000282	0.00425	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000268	0.00403	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000262	0.00395	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000254	0.00383	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000247	0.00373	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000239	0.00361	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000225	0.00339	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000197	0.00296	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000197	0.00296	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000191	0.00287	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000188	0.00284	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000183	0.00276	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	0.000179	0.0027	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000179	0.00269	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000179	0.00269	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000177	0.00267	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000174	0.00263	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000166	0.0025	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	0.000162	0.00244	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000161	0.00242	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000151	0.00228	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000144	0.00216	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000139	0.00209	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000137	0.00207	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00013	0.00196	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000119	0.00179	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000111	0.00168	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000107	0.00161	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000106	0.0016	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	0.000106	0.0016	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000106	0.00159	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000106	0.00159	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000101	0.00152	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.0001	0.00151	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.81e-05	0.00148	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AGT—dilated cardiomyopathy	9.67e-05	0.00146	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.51e-05	0.00143	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	9.07e-05	0.00137	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.22e-05	0.00124	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.12e-05	0.00122	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.7e-05	0.00116	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.71e-05	0.00101	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.62e-05	0.000997	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RAC1—dilated cardiomyopathy	5.98e-05	0.000901	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.72e-05	0.000861	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AGT—dilated cardiomyopathy	5.71e-05	0.000861	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.53e-05	0.000833	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.39e-05	0.000811	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.85e-05	0.000731	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.6e-05	0.000693	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	4.4e-05	0.000663	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	4.29e-05	0.000646	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RAF1—dilated cardiomyopathy	3.96e-05	0.000597	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	3.86e-05	0.000581	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.72e-05	0.00041	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	2.46e-05	0.000371	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	2.4e-05	0.000361	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	2.16e-05	0.000325	CbGpPWpGaD
